Nuvectis Pharma Inc.
5.46
-0.18 (-3.19%)
At close: Jan 15, 2025, 3:59 PM
5.37
-1.65%
After-hours Jan 15, 2025, 04:00 PM EST

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20
Cash & Equivalents 19.13M 19.99M 5.74M n/a
Short-Term Investments n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a
Other Long-Term Assets n/a n/a 824.00K n/a
Receivables n/a n/a n/a n/a
Inventory n/a n/a n/a n/a
Other Current Assets 59.00K 412.00K 91.00K n/a
Total Current Assets 19.18M 20.41M 5.83M n/a
Property-Plant & Equipment n/a n/a n/a n/a
Goodwill & Intangibles n/a n/a n/a n/a
Total Long-Term Assets n/a n/a 824.00K n/a
Total Assets 19.18M 20.41M 6.66M n/a
Account Payables 2.77M 2.91M 1.06M 10.00K
Deferred Revenue n/a n/a n/a n/a
Short-Term Debt n/a n/a n/a n/a
Other Current Liabilities 4.21M 3.28M 1.36M n/a
Total Current Liabilities 6.98M 6.19M 2.42M 10.00K
Long-Term Debt n/a n/a n/a n/a
Other Long-Term Liabilities n/a n/a n/a n/a
Total Long-Term Liabilities n/a 2.91M 15.25M n/a
Total Liabilities 6.98M 6.19M 17.66M 10.00K
Total Debt n/a n/a n/a n/a
Common Stock n/a 14.75B n/a n/a
Retained Earnings -54.24M -31.98M -12.90M -10.00K
Comprehensive Income n/a -14.75B 0.00 n/a
Shareholders Equity 12.20M 14.22M -11.01M -10.00K
Total Investments n/a n/a n/a n/a